Last update:

Weight management news

Obesity weakens anti-tumor immune response in lung cancer, but exercise may restore it

Obesity can weaken the immune system's tumor-killing responses in lung cancer, leading to disease progression, but a new study by experts at Roswell Park Comprehensive Cancer Center reveals that exercise may reverse this ...

Obesity drugs show early promise against the hormonal disorder PMOS, giving a suffering family hope

Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted facial hair—the same puzzling symptoms that plagued her mom for decades and that no doctor could piece ...

Unexpected brain mechanism challenges assumptions about GLP-1s

For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10% to 15% or more. Despite their success, ...

FDA approves higher-dose Wegovy to help people lose more weight

A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher dose. The U.S. Food and Drug Administration (FDA) approved a 7.2-milligram dose of Novo Nordisk's semaglutide, ...

What to know about fatty liver disease and why it's so common

Fatty liver disease is when too much fat builds up in the liver. The liver is the body's filter. It helps clean the blood, store energy and process nutrients. If too much fat stays in the liver, it can harm the organ and ...

Testosterone improves fat distribution for older women

As we age, the amount and distribution of fat in our bodies changes. Most fat is subcutaneous—meaning it is stored just under the skin. Subcutaneous fat generally does not have detrimental health impacts. In fact, we need ...

India to tackle global obesity with cheap fat-loss jabs

A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost generic versions of injections like Ozempic after a key patent expired Friday.

Stopping GLP-1 drugs can quickly erase cardiovascular benefits

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...

Research finds links among work, diet and chronic illnesses

Two related studies published recently by international teams—including researchers with the UCLA Fielding School of Public Health and the UCLA Joe C. Wen School of Nursing—examined how diabetes, heart disease and other chronic ...